Robbins Geller Rudman & Dowd LLP Announces Deadline in Walgreens Class Action Lawsuit

SAN DIEGO, Sept. 06, 2024 (GLOBE NEWSWIRE) —

The law firm of Robbins Geller Rudman & Dowd LLP has announced that purchasers or acquirers of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) securities between October 12, 2023 and June 26, 2024, inclusive have until this upcoming Tuesday, September 10, 2024 to seek appointment as lead plaintiff of the Walgreens class action lawsuit.

Known as Bhaila v. Walgreens Boots Alliance, Inc., No. 24-cv-05907 (N.D. Ill.), the lawsuit alleges that Walgreens and certain top executives violated the Securities Exchange Act of 1934.

Impact on Individuals

If you purchased or acquired Walgreens securities during the specified period, you may be eligible to participate in the class action lawsuit. Seeking appointment as lead plaintiff could potentially allow you to recover losses incurred as a result of the alleged violations by Walgreens and its executives.

Impact on the World

The outcome of the Walgreens class action lawsuit could have broader implications for the world of securities law and corporate governance. A ruling in favor of the plaintiffs could signal increased accountability for companies and executives engaging in fraudulent or misleading practices.

Conclusion

In conclusion, the deadline approaching for lead plaintiff appointment in the Walgreens class action lawsuit presents an opportunity for affected individuals to seek recourse for potential securities violations. The outcome of the lawsuit could also set a precedent for corporate accountability in the future.